patient experience

Doc Sinclair
Doc Sinclair
Family, music, rocks, fish — Doc Sinclair is a man of many passions. As he faces brain cancer, he strives to maintain an active, full life.
Doc Sinclair
Janice Armbrust
Janice Armbrust
Decades of hiking and rock climbing taught Janice Armbrust how to handle the greatest uphill battle of her life: one day — one step — at a time.
Janice Armbrust
Joël Bernier
Joël Bernier
For Joël Bernier, music has always been a source of joy and purpose. He rediscovered its power following a glioblastoma diagnosis.
Joël Bernier
Mike Hugo
Mike Hugo
Mike Hugo has packed a lot of life in his years, and he wants to teach his daughters to live with the same vigor and resolve.
Mike Hugo
Linda Long
Linda Long
Linda Long always saw the road ahead as she pursued her dream, making history in the Philadelphia Fire Department. Then she was diagnosed with glioblastoma.
Linda Long
Jovan Knutson
Jovan Knutson
A glioblastoma diagnosis led Jovan Knutson to reevaluate what is most important to her. She has found joy in the moment, and with it, a renewed sense of purpose and resilience.
Jovan Knutson
D.J. Stewart
D.J. Stewart
D.J. Stewart has a few choice words for glioblastoma, which he’s faced with defiant optimism. Now he’s joining the larger rebellion against brain cancer.
D.J. Stewart
Bruce Stahlman
Bruce Stahlman
Bruce and Kelly Stahlman found strength in gratitude as they raised, and then lost, twin boys with disabilities. They have faced Bruce’s glioblastoma with the same relentless spirit.
Bruce Stahlman

our culture

why innovation takes courage
why innovation takes courage
Joachim believes that at the heart of every innovation is courage. He communicates the stories of his colleagues to encourage others.
why innovation takes courage
supporting investigators in TTFields clinical trials
supporting investigators in TTFields clinical trials
As many physicians are using TTFields therapy for the first time to treat their patients in clinical trials, Jonathan Gephart educates them on the science and administration of TTFields therapy.
supporting investigators in TTFields clinical trials
empathy for candidates and colleagues
empathy for candidates and colleagues
Whether he is helping a manager lead a team or interviewing a candidate for an open role, Jürgen Schaller seeks to understand the other person’s perspective.
empathy for candidates and colleagues
working with patients is a privilege
working with patients is a privilege
When Caleigh Olds visits patients at their homes to provide technical support for TTFields therapy, she is motivated by their positive attitude and determination.
working with patients is a privilege
‘part of something meaningful’
‘part of something meaningful’
At Novocure, we have the opportunity to dream big and inspire one another to be the best versions of ourselves. Every day, we strive to apply knowledge, advance skills and grow personally and professionally.
‘part of something meaningful’
exploring the potential of TTFields therapy
exploring the potential of TTFields therapy
It's an exhilarating time to highlight our research leadership and demonstrate that there is much more work to be done.
exploring the potential of TTFields therapy
delivering excellence
delivering excellence
Our Global Supply Chain team is building the backbone for our anticipated growth.
delivering excellence
investing in true innovation
investing in true innovation
From the moment Lennart Perlhagen met Novocure founder Professor Yoram Palti, Lennart felt inspired by Yoram’s brilliant mind. In 2000, Yoram shared with Lennart his idea of using electric fields to treat cancer. Lennart understood the risk was very high. He knew that it would be an immense challenge to develop an entirely new cancer treatment and to bring it to patients. However, that didn’t stop him.
investing in true innovation

features

Novocure joins New Hampshire Life Sciences
Novocure joins New Hampshire Life Sciences
We will work with industry partners to champion New Hampshire’s cutting-edge life sciences sector and improve patients’ lives.
Novocure joins New Hampshire Life Sciences
extra in the ordinary
extra in the ordinary
Share stories of finding purpose and joy in simple moments while living with GBM.
extra in the ordinary
you are not alone in facing a cancer diagnosis
you are not alone in facing a cancer diagnosis
Lean on patient advocacy groups for the support you need.
you are not alone in facing a cancer diagnosis
a Q&A with our founder
a Q&A with our founder
Novocure founder Professor Yoram Palti, recipient of the 2022 Israel Prize for excellence in entrepreneurship and technological innovation, reflects on his discovery of Tumor Treating Fields.
a Q&A with our founder
Novocure pledges $250K to Families First Health and Support Center
Novocure pledges $250K to Families First Health and Support Center
We committed the lead corporate gift to the capital campaign for a New Hampshire community health center’s new home.
Novocure pledges $250K to Families First Health and Support Center
lighting the world blue
lighting the world blue
Mesothelioma Awareness Day takes place annually in the U.S. on Sept. 26.
lighting the world blue
standing with the brain tumor community
standing with the brain tumor community
As a global oncology company focusing on improving survival in some of the most aggressive forms of cancer, Novocure proudly stands with the brain tumor community during May for Brain Tumor Awareness Month (BTAM).
standing with the brain tumor community
Ignace Vergote, Novocure Clinical Trial Investigator
Ignace Vergote, Novocure Clinical Trial Investigator
Professor Ignace Vergote has dedicated his 32-year career to investigating treatment options and striving to improve survival in gynecologic cancers. Among gynecologic cancers, ovarian cancer is the deadliest, representing the fifth most common cause of cancer death among women in the United States. Five-year survival in ovarian cancer has slowly increased from 34 percent in 1975 to 47 percent today.
Ignace Vergote, Novocure Clinical Trial Investigator